Towarzystwo Funduszy Inwestycyjnych PZU SA’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.34M Sell
3,727
-293
-7% -$89.6K 0.38% 44
2026
Q1
$1.01M Buy
4,020
+3,950
+5,643% +$983K 0.34% 47
2025
Q4
$19.3K Hold
70
﹤0.01% 620
2025
Q3
$18.4K Hold
70
﹤0.01% 608
2025
Q2
$15.3K Hold
70
﹤0.01% 608
2025
Q1
$15.7K Hold
70
0.01% 598
2024
Q4
$22.9K Buy
+70
New +$22K 0.01% 512

Other funds holding WST

Towarzystwo Funduszy Inwestycyjnych PZU SA's WST Position: Q2 2026 in Review

Towarzystwo Funduszy Inwestycyjnych PZU SA reduced its West Pharmaceutical (WST) stake by 7.3% in Q2 2026, selling an estimated $89.6K and leaving 3,727 shares worth $1.34M. The position accounts for 0.38% of the portfolio, ranked #44.

Towarzystwo Funduszy Inwestycyjnych PZU SA first reported a position in WST in Q4 2024 and has held it in 7 quarters since. 565 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Towarzystwo Funduszy Inwestycyjnych PZU SA held 3,727 shares of West Pharmaceutical worth $1.34M as of Q2 2026.
  • Towarzystwo Funduszy Inwestycyjnych PZU SA sold 293 West Pharmaceutical shares in Q2 2026, an estimated $89.6K.
  • West Pharmaceutical made up 0.38% of Towarzystwo Funduszy Inwestycyjnych PZU SA's portfolio in Q2 2026, its #44 holding.
  • Towarzystwo Funduszy Inwestycyjnych PZU SA first reported a position in West Pharmaceutical in Q4 2024 and has held it in 7 quarters since.
  • 565 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Towarzystwo Funduszy Inwestycyjnych PZU SA's 13F filing for Q2 2026, filed 7 Aug 2026.